Gene · 8405
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Interplay between epigenetic modifiers and transcription factors in driving cancer progression. | Front Oncol | 2023 | 37404748 | PubTator, text mining | PubMed |
| Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors. | Proc Natl Acad Sci U S A | 2023 | 37399416 | PubTator, text mining | PubMed |
| Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy. | Genes Dis | 2023 | 37396527 | PubTator, text mining | PubMed |
| USP51/PD-L1/ITGB1-deployed juxtacrine interaction plays a cell-intrinsic role in promoting chemoresistant phenotypes in non-small cell lung cancer. | Cancer Commun (Lond) | 2023 | 37386737 | PubTator, text mining | PubMed |
| Tumor-suppressive function and mechanism of miR-873-5p in glioblastoma: evidence based on bioinformatics analysis and experimental validation. | Aging (Albany NY) | 2023 | 37382594 | PubTator, text mining | PubMed |
| Joint analysis of WES and RNA-Seq identify signature genes related to metastasis in prostate cancer. | J Cell Mol Med | 2023 | 37378426 | PubTator, text mining | PubMed |
| The Roles of Zinc Finger Proteins in Colorectal Cancer. | Int J Mol Sci | 2023 | 37373394 | PubTator, text mining | PubMed |
| Biophysical Characterization of the Binding Mechanism between the MATH Domain of SPOP and Its Physiological Partners. | Int J Mol Sci | 2023 | 37373284 | PubTator, text mining | PubMed |
| The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer. | Cancers (Basel) | 2023 | 37370720 | PubTator, text mining | PubMed |
| BRCA2 reversion mutation confers resistance to olaparib in breast cancer. | Clin Case Rep | 2023 | 37361653 | PubTator, text mining | PubMed |
| Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. | Anticancer Res | 2023 | 37351993 | PubTator, text mining | PubMed |
| Serrate RNA Effector Molecule (SRRT) Is Associated with Prostate Cancer Progression and Is a Predictor of Poor Prognosis in Lethal Prostate Cancer. | Cancers (Basel) | 2023 | 37345203 | PubTator, text mining | PubMed |
| FBXO7, a tumor suppressor in endometrial carcinoma, suppresses INF2-associated mitochondrial division. | Cell Death Dis | 2023 | 37344480 | PubTator, text mining | PubMed |
| A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer. | BMC Med Genomics | 2023 | 37337170 | PubTator, text mining | PubMed |
| The global landscape and research trend of phase separation in cancer: a bibliometric analysis and visualization. | Front Oncol | 2023 | 37333812 | PubTator, text mining | PubMed |
| Cyclin-dependent kinase 5 negatively regulates antiviral immune response by disrupting myeloid differentiation primary response protein 88 self-association. | Virulence | 2023 | 37332205 | PubTator, text mining | PubMed |
| Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge. | Arterioscler Thromb Vasc Biol | 2023 | 37317853 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the oncogenic and immunological roles of apolipoprotein F (APOF) in human cancer. | Eur J Med Res | 2023 | 37312170 | PubTator, text mining | PubMed |
| Molecular testing raises thyroid nodule fine needle aspiration diagnostic value. | Endocr Connect | 2023 | 37310413 | PubTator, text mining | PubMed |
| Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics. | Front Cell Dev Biol | 2023 | 37305676 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8405/papers?page=19